IP Library Granted Patent US 45,274
Granted Patent E1
US 45,274 · App. 14/247,942 · Granted Dec 2, 2014

Synthetic mycotoxin adsorbents and methods of making and utilizing the same

Inventors: Alexandros Yiannikouris (Lexington, KY); Stefan Kwiatkowski (Lexington, KY); Manoj Bojappa Kudupoje (Lexington, KY); Clayton Matney (Campbelsville, KY)
Assignee: Alltech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 45,274
App. No.
14/247,942
Granted
Dec 2, 2014
Kind
E1
Abstract

The present invention relates generally to molecularly imprinted polymers (MIPs). In particular, the present invention relates to reusable, ecologically friendly MIPs that can be produced in relatively large quantities, methods of producing the same, and methods of utilizing the same (e.g., to sequester and/or adsorb target compounds (e.g., mycotoxins)). Compositions and methods of the invention find use in a variety of applications including dietary therapeutic, prophylactic, food and beverage processing and manufacture, as well as research, quality control and traceability applications.

Claims (11)

1. A composition comprising a molecularly imprinted polymer synthesized using a mycotoxin template selected from the group consisting having a formula of N-(2-hydroxy-3,5-dichlorobenzoyl)-L-phenylalanine, 5-chloro-6,7-dimethoxy-1-methylisatine, ethyl 3-hydroxy-6,7-dimethoxy-2-indolone-3-carboxylate, 6,7-dimethoxyisatine, and 6,7-dimethoxy-1-methylisatine.

2. The composition of claim 1 , wherein the mycotoxin template is N-(2-hydroxy-3,5-dichlorobenzoyl)-L-phenylalanine.

3. The composition of claim 1 , wherein the mycotoxin template is 5-chloro-6,7-dimethoxy-1-methylisatine.

4. The composition of claim 1 , wherein the molecularly imprinted polymer is made by providing N-(2-hydroxy-3,5-dichlorobenzoyl)-L-phenylalanine template and one or more monomers and one or more crosslinkers; and contacting the mycotoxin template with the one or more monomers and the one or more crosslinkers under conditions that permit polymerization of the one or more monomers and the one or more crosslinkers in the presence of the template.

5. The composition of claim 4 , wherein the one or more monomers are selected from the group consisting of 2-vinylpyridine, 2-hydroxyethylmethacrylate and methacrylic acid.im 4 , wherein the one or more crosslinkers comprise ethylene

6. The composition of claglycol dimethacrylate.

7. The A composition of claim 1 , comprising a molecularly imprinted polymer synthesized using a mycotoxin wherein the molecularly imprinted polymer is made by providing N-(2-hydroxy-3,5-dichlorobenzoyl)-L-phenylalanine template selected from the group consisting of 5-chloro-6,7-dimethoxy-1-methylisatine, ethyl 3-hydroxy-6,7-dimethoxy-2-indolone-3-carboxylate, 6,7-dimethoxyisatine, and 6,7-dimethoxy-1-methylisatine; and one or more monomers and one or more crosslinkers; and contacting the mycotoxin template with the one or more monomers and the one or more crosslinkers under conditions that permit polymerization of the one or more monomers and the one or more crosslinkers in the presence of the template.

8. The composition of claim 7 , wherein the one or more monomers are selected from the group consisting of 2-vinylpyridine, 2-hydroxyethylmethacrylate and methacrylic acid.

9. The composition of claim 7 , wherein the one or more crosslinkers comprise ethylene glycol dimethacrylate.

10. A composition comprising a molecularly imprinted polymer synthesized using a mycotoxin template selected from the group consisting of 5-chloro-6,7-dimethoxy-1-methylisatine, ethyl 3-hydroxy-6,7-dimethoxy-2-indolone-3-carboxylate, 6,7-dimethoxyisatine, and 6,7-dimethoxy-1-methylisatine.

11. The composition of claim 10, wherein the molecularly imprinted polymer is made by providing the mycotoxin template and one or more monomers and one or more crosslinkers; and contacting the mycotoxin template with the one or more monomers and the one or more crosslinkers under conditions that permit polymerization of the one or more monomers and the one or more crosslinkers in the presence of the template.

Assignments (6)
SECOND LIEN PATENT SECURITY AGREEMENT Recorded Nov 14, 2024
From: ALLTECH, INC.; RIDLEY USA INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 069357/0281 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2021
From: ALLTECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 058292/0934 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS (3) Recorded Nov 30, 2021
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: ALLTECH, INC.
Reel/Frame 058282/0462 →
RELEASE OF SECURITY INTEREST Recorded Oct 26, 2021
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: ALLTECH, INC.; RIDLEY USA INC.
Reel/Frame 057919/0761 →
ASSIGNMENT FOR SECURITY -- PATENTS Recorded May 18, 2020
From: ALLTECH, INC; RIDLEY USA, INC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 052694/0412 →
PATENT SECURITY AGREEMENT Recorded Aug 17, 2015
From: ALLTECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036371/0357 →
Continuity (2)
Reissue 12870664 · Aug 27, 2010
Provisional Application 61237549 · Aug 27, 2009